DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lumacaftor
Lumacaftor
Supplementary Information
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Active Moiety Name FDA Established Pharmacologic Class (EPC) Text
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Medicines Amendment Regulations 2018
Treatment of Pulmonary Disease of Cystic Fibrosis: a Comprehensive Review
Poisons Standard February 2020
FDA-Approved Drug Library Mini (96-Well)
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
FDA-Approved Drug Library Mini (96-Well)
Annual Report 2013
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
RT 8-5 ON13 R7D.Indd
Efficacy of Lumacaftor-Ivacaftor for the Treatment of Cystic Fibrosis Patients Homozygous for the F508del-CFTR Mutation
Orphan Drug Designations and Approvals List As of 06‐01‐2015 Governs July 1, 2015 ‐ September 30, 2015
Membrane Transporter/Ion Channel Compound Library (96-Well)
AHFS Pharmacologic-Therapeutic Classification System
Top View
Prescription Drug List Products for Human
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Issue and Citation Type: M= Main Feature; L= Literature Review; F= FDA Update; C= Correction)
ATC Code Title
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016